Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time to protection and adherence requirements of Truvada and Descovy for HIV-1 prevention
2016-000439-42Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of emtricitabine + tenofovir disoproxil and tenofovir alafenamide in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Non-infection of vaginal and rectal tissue with HIV-1 at day 15. Status: unknown.
02
Drugs
emtricitabine + tenofovir disoproxiltenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2016-000439-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000439-42.